Udi E Ghitza
Biographic Data
| ID | 5836589 |
|---|---|
| NAME | Udi E Ghitza |
| GIVEN NAMES | Udi E |
| FAMILY NAME | Ghitza |
| SIGNATURE | GHITZA U E |
| AFFILIATIONS | National Institute on Drug Abuse |
| ORCID | 0000-0001-9964-8066 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Research agenda evaluating measurement-based care for opioid use disorder among patients with co-occurring depressive disorders
Buprenorphine and other medication treatments for opioid use disorder (OUD) in general medical settings are effective in preventing drug overdoses related to opioid use, although treatment retention is often challenging. Real-world data indicate high medication discontinuation rates at 6 months or greater following treatment initiation, partially indicative of a common failure to optimize medication dosing to minimize side effects, maximize thera…
An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches
As digital technology increasingly informs clinical trials, novel ways to collect study data in the natural field setting have the potential to enhance the richness of research data. Cocaine use in clinical trials is usually collected via self-report and/or urine drug screen results, both of which have limitations. This article examines the feasibility of developing a wrist-worn device that can detect sufficient physiological data (i.e., heart ra…
Commentary
GENERAL COMMENTARY article Front. Psychiatry, 25 April 2016Sec. Behavioral and Psychiatric Genetics Volume 7 - 2016 | https://doi.org/10.3389/fpsyt.2016.00073
Commentary
GENERAL COMMENTARY article Front. Psychiatry, 17 March 2016Sec. Addictive Disorders Volume 7 - 2016 | https://doi.org/10.3389/fpsyt.2016.00041
Commentary
GENERAL COMMENTARY article Front. Psychiatry, 29 September 2015Sec. Neuroimaging Volume 6 - 2015 | https://doi.org/10.3389/fpsyt.2015.00136
No prominent works on this page.
Commentary
GENERAL COMMENTARY article Front. Psychiatry, 29 September 2015Sec. Neuroimaging Volume 6 - 2015 | https://doi.org/10.3389/fpsyt.2015.00136
Commentary
GENERAL COMMENTARY article Front. Psychiatry, 25 April 2016Sec. Behavioral and Psychiatric Genetics Volume 7 - 2016 | https://doi.org/10.3389/fpsyt.2016.00073
Commentary
GENERAL COMMENTARY article Front. Psychiatry, 17 March 2016Sec. Addictive Disorders Volume 7 - 2016 | https://doi.org/10.3389/fpsyt.2016.00041
An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches
As digital technology increasingly informs clinical trials, novel ways to collect study data in the natural field setting have the potential to enhance the richness of research data. Cocaine use in clinical trials is usually collected via self-report and/or urine drug screen results, both of which have limitations. This article examines the feasibility of developing a wrist-worn device that can detect sufficient physiological data (i.e., heart ra…
Research agenda evaluating measurement-based care for opioid use disorder among patients with co-occurring depressive disorders
Buprenorphine and other medication treatments for opioid use disorder (OUD) in general medical settings are effective in preventing drug overdoses related to opioid use, although treatment retention is often challenging. Real-world data indicate high medication discontinuation rates at 6 months or greater following treatment initiation, partially indicative of a common failure to optimize medication dosing to minimize side effects, maximize thera…
Medicine (5 works) · Psychiatry (4 works) · Psychology (4 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Computer Science (2 works) · Internal Medicine (2 works) · Psychotherapist (2 works) · Addiction (1 work) · Association (psychology (1 work)